MedTrace Logo

Soberlink Within In-Home Addiction Treatment Program

NCT03902171 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-04-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.

Conditions

Interventions

DEVICE

Soberlink

Soberlink delivers real-time blood alcohol results to people who support individuals in recovery from alcohol use disorder. In-Home Addiction Treatment program Care Team monitors and responds to results as part of care to improve treatment outcomes.

Sponsors & Collaborators

  • Soberlink Healthcare LLC

    collaborator INDUSTRY

  • In-Home Addiction Treatment Institute, Inc.

    lead OTHER

Principal Investigators

  • Courtney MacNeill, LMSW · Research Associate

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-02
Primary Completion
2020-02-28
Completion
2020-09-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03902171 on ClinicalTrials.gov